These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9185703)

  • 1. Human pancreatic cancer cells (MPanc-96) recognized by autologous tumor-infiltrating lymphocytes after in vitro as well as in vivo tumor expansion.
    Peiper M; Nagoshi M; Patel D; Fletcher JA; Goegebuure PS; Eberlein TJ
    Int J Cancer; 1997 Jun; 71(6):993-9. PubMed ID: 9185703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance if ICAM-1 on lysis of human pancreatic carcinoma cells by autologous, cytotoxic T-lymphocytes].
    Peiper M; Goedegebuure PS; Eberlein TJ; Broelsch CE
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):59-62. PubMed ID: 14518213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T lymphocyte mediated recognition of human pancreatic cancer cells.
    Peiper M; Sato T; Streichert T; Eisenberger CF; Knoefel WT; Izbicki JR
    Int J Cancer; 2002 May; 99(1):88-92. PubMed ID: 11948497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer.
    Linehan DC; Goedegebuure PS; Peoples GE; Rogers SO; Eberlein TJ
    J Immunol; 1995 Nov; 155(9):4486-91. PubMed ID: 7594611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for cytotoxic T lymphocyte response against human lung cancer: reconstitution of antigenic epitope with peptide eluted from lung adenocarcinoma MHC class I.
    Calhoun RF; Naziruddin B; Enriquez-Rincon F; Duffy BF; Ritter JM; Sundaresan S; Patterson GA; Cooper JD; Mohanakumar T
    Surgery; 2000 Jul; 128(1):76-85. PubMed ID: 10876189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
    Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
    J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell receptor gene structures of HLA-A26-restricted cytotoxic T lymphocyte lines against human autologous pancreatic adenocarcinoma.
    Ueda D; Sato N; Matsuura A; Sasaki A; Takahashi S; Ikeda H; Wada Y; Kikuchi K
    Jpn J Cancer Res; 1995 Jul; 86(7):691-7. PubMed ID: 7559088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes.
    Peiper M; Goedegebuure PS; Linehan DC; Ganguly E; Douville CC; Eberlein TJ
    Eur J Immunol; 1997 May; 27(5):1115-23. PubMed ID: 9174600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and molecular characterization of a new human ampullary cancer cell line.
    Peiper M; Alldinger I; Heller R; Pilarsky C; Schumacher U; Knoefel WT; Heinecke A; Izbicki JR
    Anticancer Res; 2003; 23(1A):291-8. PubMed ID: 12680226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.
    Seki N; Hoshino T; Kikuchi M; Hayashi A; Itoh K
    Cell Immunol; 1997 Feb; 175(2):101-10. PubMed ID: 9023415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones.
    Wölfel T; Herr W; Coulie P; Schmitt U; Meyer zum Büschenfelde KH; Knuth A
    Int J Cancer; 1993 Jun; 54(4):636-44. PubMed ID: 8514455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
    Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA
    J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3(+)CD56(+) (natural killer T) lymphocytes.
    Baxevanis CN; Gritzapis AD; Tsitsilonis OE; Katsoulas HL; Papamichail M
    Int J Cancer; 2002 Apr; 98(6):864-72. PubMed ID: 11948464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment and characterization of human pancreatic adenocarcinoma cell line JHP-1 producing carbohydrate antigen 19-9 and carcinoembryonic antigen].
    Sujino H; Nagamori S; Fujise K; Hasumura S; Homma S; Matsuura T; Shimizu K; Niiya M; Kameda H
    Hum Cell; 1988 Jun; 1(2):250-5. PubMed ID: 2979202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
    Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
    Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
    Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tsunoda T; Nakatsuru S; Nakagawa H; Nakamura Y; Baba H; Nishimura Y
    Clin Cancer Res; 2008 Oct; 14(20):6487-95. PubMed ID: 18927288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model.
    Oflazoglu E; Elliott M; Takita H; Ferrone S; Henderson RA; Repasky EA
    J Transl Med; 2007 Jun; 5():29. PubMed ID: 17592641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.
    Stevens EJ; Jacknin L; Robbins PF; Kawakami Y; el Gamil M; Rosenberg SA; Yannelli JR
    J Immunol; 1995 Jan; 154(2):762-71. PubMed ID: 7814882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites.
    Ioannides CG; Platsoucas CD; Rashed S; Wharton JT; Edwards CL; Freedman RS
    Cancer Res; 1991 Aug; 51(16):4257-65. PubMed ID: 1868446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.